The neurocognitive effects of low-dose haloperidol: A two-year comparison with risperidone

Biological Psychiatry

Volumn 51, Issue 12, 2002, Pages 972-978

  Green, Michael F ^a,b   Marder, Stephen R ^a,b   Glynn, Shirley M ^b,c   McGurk, Susan R ^d   Wirshing, William C ^b,c   Wirshing, Donna A ^b,c   Liberman, Robert P ^b   Mintz, Jim ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Antipsychotic medications; Cognitive deficits; Haloperidol; Neurocognition; Risperidone; Schizophrenia

Indexed keywords

HALOPERIDOL; RISPERIDONE;

ADULT; ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; TREATMENT OUTCOME;

ADULT; ANTIPSYCHOTIC AGENTS; COGNITION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HALOPERIDOL; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; RISPERIDONE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0037097453     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(02)01370-7     Document Type: Article

References (27)

1. Cognitive effects of typical antipsychotic treatment: Another look
2. Neuroleptics: Effects on neuropsychological function in chronic schizophrenic patients
3. Atypical antipsychotics in the treatment of schizophrenia: Systematic overview and meta-regression analysis
4. Recent and remote memory dissociation: Medication effects and hippocampal function in schizophrenia
5. Neurocognitive functioning in patients with schizophrenia
6. What are the functional consequences of neurocognitive deficits in schizophrenia?
7. Neurocognitive deficits and functional outcome in schizophrenia: Are we measuring the "right stuff"?
8. Studies of the cognitive change in patients with schizophrenia following novel antipsychotic treatment
9. Treatment of cognitive deficits with olanzapine or low-dose haloperidol in first episode psychosis
10. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: A review and meta-analysis
11. Antipsychotic and anticholinergic effects on two types of spatial memory in schizophrenia
12. The effect of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia
13. Signal detection in vigilance tasks and behavioral attributes among offspring of schizophrenic mothers and among hyperactive children
14. Schizophrenic performance when distractors are present: Attentional deficit or differential task difficulty?
15. Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, and haloperidol
16. Neuropsychological performance in chronic schizophrenia in response to neuroleptic dose reduction
17. Training and quality assurance with the brief psychiatric rating scale: 'The Drift Busters'